References

Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future

10.1177/2042098620938595 · 2020 · External reference

Adverse drug event reporting systems: a systematic review

10.1111/bcp.12944 · 2016 · External reference

A Bayesian neural network method for adverse drug reaction signal generation

10.1007/s002280050466 · 1998 · External reference

The reporting of studies conducted using observational routinely-collected health data (RECORD) statement

10.1371/journal.pmed.1001885 · 2015 · External reference

Updated classification of epileptic seizures: position paper of the international league against epilepsy

10.1111/epi.18338 · 2025 · External reference

Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. a systematic review

10.1111/bcp.12645 · 2015 · External reference

World Allergy Organization anaphylaxis guidance 2020

10.1016/j.waojou.2020.100472 · 2020 · External reference

Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems

10.1002/pds.4970 · 2020 · External reference

The epidemiology of drug-related hospital admissions in paediatrics: a systematic review

10.1186/s13690-024-01295-4 · 2024 · External reference

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

10.1002/pds.677 · 2001 · External reference

Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data

10.1038/s41598-024-74505-2 · 2024 · External reference

AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury

10.1002/hep.32689 · 2023 · External reference

The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): development and statement

10.1007/s40264-024-01421-9 · External reference

The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration

10.1007/s40264-024-01423-7 · External reference

A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development

10.1016/j.medj.2022.06.001 · 2022 · External reference

The Reactome pathway knowledgebase 2022

10.1093/nar/gkab1028 · 2022 · External reference

Challenges and opportunities in accessing and analysing FAERS data: a call towards a collaborative approach

10.1007/s40264-023-01345-w · 2023 · External reference

Knowledge graphs in pharmacovigilance: a scoping review

10.1016/j.clinthera.2024.06.003 · 2024 · External reference

Unresolved reference

2026 · External reference

Adverse drug reaction signal detection methods in spontaneous reporting system: a systematic review

10.1002/pds.5768 · 2024 · External reference

LightGBM: a highly efficient gradient boosting decision tree

2017 · External reference

Pharmacovigilance: the evolution of drug safety monitoring

10.1080/20523211.2024.2417399 · 2024 · External reference

Managing drug-induced QT prolongation in clinical practice

10.1136/postgradmedj-2020-138661 · 2021 · External reference

KDIGO clinical practice guideline for acute kidney injury

2012 · External reference

Navigating duplication in pharmacovigilance databases: a scoping review

10.1136/bmjopen-2023-081990 · 2024 · External reference

Unresolved reference

2026 · External reference

ChEMBL: towards direct deposition of bioassay data

10.1093/nar/gky1075 · 2019 · External reference

Normalized names for clinical drugs: RxNorm at 6 years

10.1136/amiajnl-2011-000116 · 2011 · External reference

Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems

10.1007/s40264-015-0265-0 · 2015 · External reference

Aioli: standardising drugs in the FDA adverse event reporting system (FAERS) to RxNorm and anatomical therapeutic chemical (ATC) codes

10.1002/pds.70216 · 2025 · External reference

Scikit-learn: Machine Learning in Python

2011 · External reference

Unresolved reference

2026 · External reference

Moderate and serious adverse reactions to antimicrobials among hospitalized children: a systematic review

10.1111/bcp.16153 · 2024 · External reference

Unresolved reference

2026 · External reference

Extended-connectivity fingerprints

10.1021/ci100050t · 2010 · External reference

Pediatric acute kidney injury: new advances in the last decade

10.23876/j.krcp.20.074 · 2021 · External reference

Adverse drug reactions in children: a systematic review

10.1371/journal.pone.0024061 · 2012 · External reference

Machine learning prediction of pediatric adverse drug reactions using consensus-derived scarce data

10.1038/s42004-025-01865-9 · 2026 · External reference

DrugCentral: online drug compendium

10.1093/nar/gkw993 · 2017 · External reference

Unresolved reference

2022 · External reference

Unresolved reference

2026 · External reference

Unresolved reference

2026 · External reference

Off-label, but on-evidence? A review of the level of evidence for pediatric pharmacotherapy

10.1002/cpt.2736 · 2022 · External reference

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions

10.1002/pds.668 · 2002 · External reference

The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

10.1371/journal.pmed.0040296 · 2007 · External reference

Unresolved reference

2026 · External reference